In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Artificial intelligence is rapidly reshaping the mortgage industry, boosting productivity, reducing manual work, and accelerating loan closings. From automated document data extraction to AI‑generated underwriting narratives and predictive analytics, lenders are using new tools that improve accuracy and drastically speed up processing times. With chatbots, next‑gen point‑of‑sale systems, and end‑to‑end automation, preapprovals that once took days now take minutes. For mortgage and real estate professionals, mastering AI is becoming a major competitive advantage—one that defines who will thrive in the future of lending.
Florida’s property insurance rates are finally starting to drop, but many homeowners are still seeing higher monthly bills. The reason isn’t insurer price hikes—it’s soaring replacement costs driven by construction inflation, labor shortages, and rising home values. Nearly 75 percent of recent premium increases came from higher property values alone. Understanding this gap between “rates” and “premiums” helps homeowners—and real estate and insurance professionals—navigate the shifting Florida market and make smarter coverage decisions.
Milwaukee’s commercial real estate market is finally showing real signs of recovery, with 2025 sales volume hitting a three‑year high and investor confidence steadily returning. Driven by selective, fundamentals‑focused buying—favoring strong cash flow, quality assets, and strategic pricing—the city is moving from a period of correction into a healthier, opportunity‑rich phase. For real estate professionals nationwide, Milwaukee’s momentum reflects broader CRE market stabilization and the growing importance of disciplined underwriting and market expertise.
Industry leaders project a major surge in reverse mortgage activity heading into 2026, fueled by rising proprietary products, lender innovation, and strong investor interest. As high interest rates push originators to adopt new strategies, flexible private‑label options, senior‑focused HELOCs, and a wave of big‑capital investment are reshaping the market. With education and policy shifts poised to unlock even more demand, reverse mortgages are entering their most transformative era yet.
Experts forecast that 2026 may bring long‑awaited relief to homebuyers, with both existing and new home inventory expected to rise. NAR predicts a boost in home sales, a slight drop in mortgage rates, and a modest 4% increase in prices—conditions that could motivate more homeowners to list while builders add over a million new homes to the market. For first‑time buyers, higher loan limits and easing qualification standards may make entering the market more achievable than in recent years.
South Florida enters 2026 with renewed optimism as falling mortgage rates, improving buyer confidence, and a strong job market help stabilize a housing landscape that struggled in 2025—especially in the condo sector. While single-family homes remained resilient last year, condos faced price drops, rising fees, and hesitation tied to new safety regulations. With rates projected to fall to around 5.8% by year’s end, buying power is increasing, inventory may loosen, and activity is expected to pick up. Still, affordability challenges persist, Miami’s rental market remains intensely competitive, and the condo sector’s recovery will take time.
The Mortgage Industry’s AI Transformation: Automation Reshapes Lending From Application to Approval Gallery
